FDA Approves Lumvoa for Thyroid Eye Disease, Including Chronic Cases
The second IGF-1R antibody cleared for the condition extends targeted treatment to patients in both active and chronic stages, its developer says.
Health News
Health News covers regulatory and clinical developments as they are issued: approvals, recalls, safety communications and guideline revisions. Each report names the issuing authority, describes who is affected, and states what action a reader should take. Filed quickly, and corrected openly whenever facts change.
Drug approvals, product recalls, safety advisories and revised clinical guidance, written so a reader knows immediately whether it applies to them.
FDA Approves First Oral Antiviral to Prevent COVID-19 After Exposure
Xocova (ensitrelvir) cut the risk of symptomatic infection by about 67 percent in the SCORPIO-PEP trial and is cleared for people 12 and older.
FDA Approves Foundayo, an Oral GLP-1 Pill for Weight Management
Eli Lilly's orforglipron delivered an average 12.4 percent weight loss at the highest dose in trials and can be taken without food or water restrictions.
FDA Approves First-Ever Treatment for Menkes Disease in Children
The agency cleared copper histidinate injection, ending a decades-long stretch in which care for the rare copper-transport disorder was supportive only.